Latest news

  • Pelvic organ prolapse treatment closer

    A revolutionary technology to treat pelvic organ prolapse is one step closer after the latest results from a Hudson Institute study.…  Read more

  • Crohn’s disease diagnosis impacts future health

    Crohn’s disease is an incurable inflammatory bowel disease (IBD) affecting more than 60,000 Australians, including children.…  Read more

  • Fetal growth restriction findings

    Treatments given postnatally to babies who have experienced fetal growth restriction (FGR) during pregnancy need to be carefully considered, following new light shed on the topic by cell therapy research.…  Read more

  • NHMRC Investigator Grants success

    Hudson Institute is delighted to announce the success of our researchers in the latest NHMRC Investigator Grant round. Internationally-renowned childhood sleep expert Professor Rosemary Horne has been awarded more than $2 million to pursue studies investigating the implications of impaired sleep on the developing brain, while Dr Jun Yang has been awarded more than half…  Read more

    National Health and Medical Research Council Investigator Grants
  • $2.2 million awarded to tackle rare ovarian cancer

    Women with a rare and potentially aggressive form of ovarian cancer will benefit from a grant to continue ground-breaking research into new detection and treatment methods.…  Read more

  • Male infertility expert joins Hudson Institute

    Dr Robin Hobbs has joined Hudson Institute as Group Head, Germline Stem Cell Biology. We welcome him and his team, including postdoctoral scientists Dr Ai-Leen Chan and Dr Julien Legrand, and PhD student Mai La.…  Read more

  • Cell therapies trial planned for COVID-19

    More than 200,000 people have died from COVID-19 since January 2020. While Australia has been relatively spared from the onslaught of infections and deaths, our nation’s scientists need to be part of the global effort to address this pandemic.…  Read more

  • Using our immune system to fight COVID-19

    There is something unusual about the initial—or innate—immune response to COVID-19 compared to usual influenza patterns. …  Read more

  • Inflammation and infectious diseases

    Severe COVID-19 infection presents as excessive lung inflammation, involving the build-up of cells and fluid in the lungs. This phenomenon, known as ARDS, restricts breathing and causes damage to the lungs. Severely affected patients will need ventilator assistance in intensive care.…  Read more

  • Hyper-acute inflammation in COVID-19

    Sepsis is a hyper-acute inflammatory response leading to life-threatening organ dysfunction. Sepsis is usually caused by bacterial infections; however, the COVID-19 pandemic illustrates that hyper-acute inflammation can also be part of viral infections.…  Read more

    Dr Michael Gantier from the Nucleic Acids and Innate Immunity Research Group at Hudson Institute